News
The addition of Tavros greatly expands Vividion’s functional ... with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all ...
Tavros Capital and Charney Companies bought the full-block site along the Gowanus Canal from Property Markets Group for $102 million in 2022, with the ink barely dry on the new zoning. It is three ...
An attention-grabbing design by prominent Brooklyn architecture firm Bjarke Ingels Group, or BIG, for a parking lot on the ... remediated and with a valuable 421-a tax break. Developers Tavros Capital ...
Until 2023, it was a member of the largest international bakery group Lantmännen Unibake with its head office in Denmark. In August 2023, it became part of the Tavros Group. Also in 2023, it became ...
DURHAM – The precision oncology startup Tavros Therapeutics has closed $7. ... scalability to address critical unmet needs in cancer care,” said Long, in the statement. “ ...
Charney Companies, a fully integrated real-estate development, construction, brokerage, and management company, and Tavros ... alternative asset management group Tikehau Capital.
Tavros Therapeutics, a startup with ties to Duke University, is partnering with California-based OpenBench to discover new cancer drugs. Through a recent collaboration agreement, the companies aim ...
DURHAM, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company, today announced that the Company has achieved two milestone payments in its ...
Charney Cos. and Tavros Capital have purchased an empty lot bordering the Gowanus Canal for $164 million, according to an April 30 deed that appeared in the city register Tuesday. The two firms ...
“We tried to take advantage of all the characteristics of the old that make it special and unique and interesting.” Owner Tavros saw the potential of this irregular block of buildings at the edge of ...
Vividion is a wholly owned and independently operating subsidiary of Bayer AG. The addition of Tavros greatly expands Vividion’s functional genomics expertise and capabilities, bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results